The organ preservation solutions market in Europe is expected to grow from US$ 60.54 million in 2021 to US$ 91.48 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2021 to 2028.
France, Germany, Spain, Italy, and UK are major economies in Europe. The prevalence of chronic diseases leading to kidney failure is rising and this is the major factor driving the growth of the Europe organ preservation solutions market. A kidney transplant is the most common organ transplant around the world. According to the World Health Organization (WHO), nearly 41% share is held by kidney transplants, compared to other organ transplants Additionally, a study published by the National Kidney Foundation in 2020 predicted that approximately 35.0% of the diabetic population over the age of 20 would develop chronic kidney disease over time.The National Kidney Foundation also reported that CKD is expected to kill more people in 2021 than prostate or breast cancer. It is a widely under-recognized emergency health condition. 1 in every 3 American adults (approximately 80 million people) is at risk of developing chronic kidney disease. According to the estimates given by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. These factors are expected to enhance market growth during the forecast period.In all European countries, the COVID-19 pandemic resulted in a significant reduction in living and deceased organ donation and transplantation activities. In the United Kingdom, the peak decline was over 80%. The reduction varied between locations within a country and was different for deceased and living donors. In the United Kingdom, there was early signs of deceased donation recovery. Despite considerable resource redirection to combat the epidemic, certain policy modifications were implemented at the national and transplant center levels to ensure safe transplantation. The National Health Service (NHS) Blood and Transplant changed the age acceptance requirements for dead donors on March 23, 2020, the same day the UK Government announced lockdown limitations, to protect ICU bed capacity and maximize the utilization of organs available for transplantation. The maximum age for brain death donation was reduced from 85 to 60 years (increasing to 75 years from April 7, 2020), and the maximum age for circulatory death donation was reduced from 80 to 50 years. In normal circumstances, these adjustments would result in a 47 percent reduction in actual donor numbers. The COVID
-
19 pandemic worst impacts hospital services. The hospitals are overloaded with COVID-
19 patients and other routine patients. Many organ donation specialists were reassigned to various tasks in ICUs and other COVID-19-related programmes. Patients on the highly urgent liver and heart transplantation lists were given transplant priority. Due to the ongoing pandemic situation in the European regions, the hospitals in countries such as the UK, Italy, Germany, and others are affected worst affected. Thus, the COVID-
19 has a negative impact on the organ preservation solution market in the region.With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe organ preservation solutions market. The Europe organ preservation solutions market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Organ Preservation Solutions Market Segmentation
Europe Organ Preservation Solutions Market – By Solution
- University of Wisconsin Solution (UW)
- Custodiol HTK
- Perfadex
- Others
Europe Organ Preservation Solutions Market – By Technique
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Others
Europe Organ Preservation Solutions Market – By Organ Type
- Kidneys
- Liver
- Lungs
- Heart
- Others
Europe Organ Preservation Solutions Market, by Country
- France
- Germany
- Italy
- Spain
- U.K.
- Rest of Europe
Europe Organ Preservation Solutions Market - Companies Mentioned
- Accord Healthcare
- Bridge to Life Ltd
- Dr. Franz Koehler Chemie GmbH
- OrganOx Limited
- Paragonix Technologies, Inc
- TransMedics
- Waters Medical Systems LLC
- XVIVO Perfusion
Europe Organ Preservation Solutions Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 60.54 Million |
Market Size by 2028 | US$ 91.48 Million |
Global CAGR (2021 - 2028) | 6.1% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Solution
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset


- Legal Case Management Software Market
- Vessel Monitoring System Market
- Sandwich Panel Market
- Railway Braking System Market
- Ketogenic Diet Market
- Europe Surety Market
- Transdermal Drug Delivery System Market
- Electronic Health Record Market
- Nurse Call Systems Market
- Airport Runway FOD Detection Systems Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
- Accord Healthcare
- Bridge to Life Ltd
- Dr. Franz Koehler Chemie GmbH
- OrganOx Limited
- Paragonix Technologies, Inc
- TransMedics
- Waters Medical Systems LLC
- XVIVO Perfusion